Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | EXP | | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of CDCA7L mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 3,7-dihydropurine-6-thione | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of CDCA7L mRNA | CTD | PMID:23358152 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA7L mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | EXP | | 6480464 | Fenretinide results in decreased expression of CDCA7L mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Propylthiouracil results in increased expression of CDCA7L mRNA | CTD | PMID:24780913 | acetamide | increases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | acetamide results in increased expression of CDCA7L mRNA | CTD | PMID:31881176 | acrolein | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDCA7L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDCA7L mRNA | CTD | PMID:32699268 | acrylamide | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Acrylamide results in decreased expression of CDCA7L mRNA | CTD | PMID:32763439 | aflatoxin B1 | affects expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Aflatoxin B1 affects the expression of CDCA7L protein | CTD | PMID:20106945 | aflatoxin B1 | increases methylation | ISO | CDCA7L (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of CDCA7L intron | CTD | PMID:30157460 | aflatoxin B1 | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of CDCA7L mRNA | CTD | PMID:22100608 | Aflatoxin B2 alpha | increases methylation | ISO | CDCA7L (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of CDCA7L intron | CTD | PMID:30157460 | all-trans-retinoic acid | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of CDCA7L mRNA | CTD | PMID:17218384 more ... | alpha-pinene | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDCA7L mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of CDCA7L mRNA | CTD | PMID:32699268 | aristolochic acid A | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of CDCA7L mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of CDCA7L mRNA | CTD | PMID:25270620 | arsane | affects methylation | ISO | CDCA7L (Homo sapiens) | 6480464 | Arsenic affects the methylation of CDCA7L gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | CDCA7L (Homo sapiens) | 6480464 | Arsenic affects the methylation of CDCA7L gene | CTD | PMID:25304211 | azathioprine | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of CDCA7L mRNA | CTD | PMID:22623647 | benzo[a]pyrene | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of CDCA7L mRNA | CTD | PMID:20064835 | benzo[a]pyrene | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of CDCA7L mRNA | CTD | PMID:32234424 | bisphenol A | affects expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | bisphenol A affects the expression of CDCA7L mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | CDCA7L (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of CDCA7L gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of CDCA7L mRNA | CTD | PMID:30816183 more ... | bisphenol A | increases methylation | ISO | Cdca7l (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of CDCA7L gene | CTD | PMID:28505145 | bisphenol A | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | bisphenol A results in increased expression of CDCA7L mRNA | CTD | PMID:27685785 | bisphenol F | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA7L mRNA | CTD | PMID:28628672 | cadmium dichloride | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of CDCA7L mRNA | CTD | PMID:26472689 | calcitriol | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Calcitriol results in decreased expression of CDCA7L mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA7L mRNA | CTD | PMID:21592394 | CGP 52608 | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to CDCA7L gene] | CTD | PMID:28238834 | clofibrate | decreases expression | EXP | | 6480464 | Clofibrate results in decreased expression of CDCA7L mRNA | CTD | PMID:25270620 | cobalt dichloride | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of CDCA7L mRNA | CTD | PMID:19320972 | copper atom | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CDCA7L mRNA | CTD | PMID:20971185 | copper(0) | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CDCA7L mRNA | CTD | PMID:20971185 | copper(II) sulfate | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of CDCA7L mRNA | CTD | PMID:19549813 | coumarin | increases phosphorylation | ISO | CDCA7L (Homo sapiens) | 6480464 | coumarin results in increased phosphorylation of CDCA7L protein | CTD | PMID:35688186 | coumestrol | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Coumestrol results in increased expression of CDCA7L mRNA | CTD | PMID:19167446 | Cuprizon | increases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Cuprizone results in increased expression of CDCA7L mRNA | CTD | PMID:26577399 | cycloheximide | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | Cycloheximide inhibits the reaction [TAK-243 results in increased sumoylation of CDCA7L protein] | CTD | PMID:31285264 | cyclosporin A | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of CDCA7L mRNA | CTD | PMID:20106945 | dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of CDCA7L mRNA | CTD | PMID:22733784 | dexamethasone | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA7L mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CDCA7L mRNA | CTD | PMID:17361019 and PMID:21266533 | dorsomorphin | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Enterolactone | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA7L mRNA | CTD | PMID:19167446 | entinostat | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | entinostat results in increased expression of CDCA7L mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCA7L mRNA | CTD | PMID:27188386 | gentamycin | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of CDCA7L mRNA | CTD | PMID:33387578 | hypochlorous acid | decreases expression | EXP | | 6480464 | Hypochlorous Acid results in decreased expression of CDCA7L mRNA | CTD | PMID:19376150 | indometacin | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of CDCA7L mRNA | CTD | PMID:28628672 | lead(0) | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Lead results in decreased expression of CDCA7L mRNA | CTD | PMID:19921347 | lidocaine | increases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Lidocaine results in increased expression of CDCA7L mRNA | CTD | PMID:35283115 | mercaptopurine | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of CDCA7L mRNA | CTD | PMID:23358152 | methoxychlor | affects methylation | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Methoxychlor affects the methylation of CDCA7L gene | CTD | PMID:35440735 | methylmercury chloride | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of CDCA7L mRNA | CTD | PMID:28001369 | ozone | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of CDCA7L mRNA more ... | CTD | PMID:32699268 | ozone | multiple interactions | EXP | | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in increased expression of CDCA7L mRNA | CTD | PMID:34911549 | PCB138 | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CDCA7L mRNA | CTD | PMID:20813756 | potassium chromate | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of CDCA7L mRNA | CTD | PMID:22714537 | pravastatin | affects expression | EXP | | 6480464 | Pravastatin affects the expression of CDCA7L mRNA | CTD | PMID:27225895 | pravastatin | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Pravastatin results in decreased expression of CDCA7L mRNA | CTD | PMID:27225895 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CDCA7L mRNA | CTD | PMID:21278054 | purine-6-thiol | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Mercaptopurine results in decreased expression of CDCA7L mRNA | CTD | PMID:23358152 | quercetin | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Quercetin results in decreased expression of CDCA7L mRNA | CTD | PMID:21632981 | resveratrol | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CDCA7L mRNA | CTD | PMID:19167446 | SB 431542 | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | sodium arsenite | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of CDCA7L mRNA | CTD | PMID:29301061 | tamoxifen | increases expression | EXP | | 6480464 | Tamoxifen results in increased expression of CDCA7L mRNA | CTD | PMID:17555576 | testosterone | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA7L mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Testosterone results in decreased expression of CDCA7L mRNA | CTD | PMID:21592394 | thapsigargin | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Thapsigargin results in decreased expression of CDCA7L mRNA | CTD | PMID:22378314 | thioacetamide | increases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of CDCA7L mRNA | CTD | PMID:34492290 | Tributyltin oxide | decreases expression | EXP | | 6480464 | bis(tri-n-butyltin)oxide results in decreased expression of CDCA7L mRNA | CTD | PMID:25270620 | trichostatin A | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | trichostatin A results in increased expression of CDCA7L mRNA | CTD | PMID:24935251 and PMID:26272509 | trichostatin A | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCA7L mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Triclosan results in decreased expression of CDCA7L mRNA | CTD | PMID:30510588 | troglitazone | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | troglitazone results in decreased expression of CDCA7L mRNA | CTD | PMID:19140230 | tunicamycin | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Tunicamycin results in decreased expression of CDCA7L mRNA | CTD | PMID:22378314 | urethane | decreases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Urethane results in decreased expression of CDCA7L mRNA | CTD | PMID:28818685 | valproic acid | affects expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Valproic Acid affects the expression of CDCA7L mRNA | CTD | PMID:25979313 | valproic acid | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCA7L mRNA | CTD | PMID:27188386 | valproic acid | increases expression | ISO | CDCA7L (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of CDCA7L mRNA | CTD | PMID:23179753 more ... | vorinostat | multiple interactions | ISO | CDCA7L (Homo sapiens) | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CDCA7L mRNA | CTD | PMID:27188386 | zaragozic acid A | decreases expression | ISO | Cdca7l (Rattus norvegicus) | 6480464 | squalestatin 1 results in decreased expression of CDCA7L mRNA | CTD | PMID:27225895 | zaragozic acid A | decreases expression | EXP | | 6480464 | squalestatin 1 results in decreased expression of CDCA7L mRNA | CTD | PMID:27225895 | |